Living Donor Liver Transplantation: Usefulness of Hemostatic and Prothrombotic Screening in Potential Donors
Rosalía Bustelos(Hospital Universitario del Sureste), Carmen Ribera(Research Institute Hospital 12 de Octubre), E. Moreno(Vall d'Hebron Hospital Universitari), Silvia Grande(Research Institute Hospital 12 de Octubre), Myriam Martin(Research Institute Hospital 12 de Octubre), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), J.C. Meneu, Cristina Garfia(Research Institute Hospital 12 de Octubre), Rosa Ayala(Hospital Universitario 12 De Octubre), T. Toledo(Research Institute Hospital 12 de Octubre)
Cited by 17
Related Papers
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523